Literature DB >> 6299117

Mechanism of action of cholecystokinin octapeptide on rat antrum, pylorus, and duodenum.

U Scheurer, L Varga, E Drack, H R Bürki, F Halter.   

Abstract

The mechanism of action of cholecystokinin octapeptide (CCK-OP) on tonic and phasic contraction of antral, pyloric, and duodenal smooth muscles was studied with a novel perfusion manometric system in isolated esophagogastroduodenal preparations of the rat. CCK-OP increased baseline pressure at each site, frequencies of phasic contractions in the antrum and pylorus, and amplitudes in the duodenum. It decreased antral and pyloric amplitudes and frequency of duodenal phasic contractions. CCK-OP action on tonic contraction was tetradotoxin (TTX) susceptible and its action on phasic contractions was TTX resistant. Phentolamine, phenoxybenzamine, propranolol, catecholamine depletion of preparations by reserpine-tetrabenazine, and the block of catecholamine synthesis at different levels significantly inhibited CCK-OP-induced tonic contraction, whereas atropine had no influence. Adrenergic and cholinergic neural actions on phasic contractions altered the level of amplitudes and frequencies on which CCK-OP action occurred. It is concluded that CCK-OP action on tonic contraction of the rat gastroduodenal junction is mediated by a neural noncholinergic pathway, whereas its effect on muscles responsible for phasic contractions is a direct one.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6299117     DOI: 10.1152/ajpgi.1983.244.3.G266

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Relation between cholecystokinin and antral innervation in the control of gastric emptying in the rat.

Authors:  A Higham; C Vaillant; B Yegen; D G Thompson; G J Dockray
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

2.  Control of gallbladder contractions by cholecystokinin through cholecystokinin-A receptors on gallbladder interstitial cells of Cajal.

Authors:  Dan Xu; Bao-Ping Yu; He-Sheng Luo; Ling-Dan Chen
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.